{"symbol": "ORGS", "companyName": "Orgenesis Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.orgenesis.com", "description": "Orgenesis Inc is engaged in developing clinical stage technology that with the capacity to induce a shift in developmental fate of cells from liver & converting them into pancreatic beta cell like insulin producing cells for patients with Type 1 Diabetes.", "CEO": "Vered Caplan", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}